Add like
Add dislike
Add to saved papers

Penile dermal flap for defect reconstruction in Peyronie's disease: operative technique and four years' experience in 17 patients.

Peyronie's disease is not uncommon. Despite its self-limiting nature in many patients and the multiplicity of available non-invasive treatment modalities, a few patients will eventually require surgery if deformity or impotence is severe and conservative measures have failed. Currently available operations for Peyronie's disease are less than ideal. The two most popular operations employed for this condition are the 'tucking' procedure of Nesbit (and its excision-plication variants) and the free dermal graft of Horton and Devine. In addition, many other autografts and synthetic grafts have been described by different workers. Some have used prostheses in these patients for straightening the penis in the absence of proven concomitant organic impotence. Unfortunately, none of these operations has fulfilled all desiderata. The author has worked at developing a live graft source (flap) which is free from many of the drawbacks experienced with other procedures. In this new operation, dermabraded penile dermis is raised on its vascular fascial pedicle and used to close the defect in the tunica albuginea consequent upon plaque incision. This technique is feasible in both circumcised and uncircumcised patients. This is the first report of the use of a flap in Peyronie's disease. Operative technique and results in 17 patients over 4 years are presented. The author's experience seems to suggest that this is an ideal operation for Peyronie's disease.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app